CVS Health: Q2 Earnings Insights

 

Shares of CVS Health CVS rose 0.5% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share decreased 8.33% over the past year to $2.42, which beat the estimate of $2.06.

Revenue of $72,616,000,000 rose by 11.13% year over year, which beat the estimate of $70,110,000,000.

Guidance

The upcoming fiscal year's EPS expected to be between $7.70 and $7.80.

Conference Call Details

Date: Aug 04, 2021

Time: 08:00 AM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg30.jsp&referrer=&eventid=3193214&sessionid=1&key=081A2966ED1835696EF6A0CFB3A271BA&regTag=&V2=false&sourcepage=register

Technicals

Company's 52-week high was at $90.61

52-week low: $55.36

Price action over last quarter: Up 1.70%

Company Profile

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with over 23 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...